drug development

GSK poaches new drug development chief Chris Corsico from Boehringer, dividing R&D into two groups
GSK poaches new drug development chief Chris Corsico from Boehringer, dividing R&D into two groups
Endpoints
GSK
R&D
drug development
Flag link:
Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field
Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field
Fierce Pharma
JNJ
innovation
R&D
lung cancer
drug development
Flag link:
Needed vaccines against HIV, malaria and tuberculosis unlikely to launch at current funding levels: study
Needed vaccines against HIV, malaria and tuberculosis unlikely to launch at current funding levels: study
Fierce Pharma
drug development
vaccines
HIV
tuberculosis
malaria
Flag link:
Elevian set up to pursue disputed approach to aging diseases
Elevian set up to pursue disputed approach to aging diseases
Fierce Biotech
Elevian
age-related disease
GDF11
drug development
Flag link:
Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases
Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases
CP Wire
antibiotics
Boehringer Ingelheim
drug development
Flag link:
Researchers Use CRISPR to Treat Duchenne Muscular Dystrophy in Dogs
Researchers Use CRISPR to Treat Duchenne Muscular Dystrophy in Dogs
BioSpace
DMD
Duchenne Muscular Dystrophy
CRISPR
drug development
Flag link:
FDA Launches Pilot Program in Support of Complex Trial Designs for Drugs and Biologics
FDA Launches Pilot Program in Support of Complex Trial Designs for Drugs and Biologics
RAPS.org
FDA
clinical trials
drug development
Flag link:
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Pharmaforum
Roche
Genentech
Affimed
cancer immunotherapy
drug development
Flag link:
Computer Program Can Predict How Cancer Tumors Will Respond to Drugs Before Dosing Begins
Computer Program Can Predict How Cancer Tumors Will Respond to Drugs Before Dosing Begins
BioSpace
cancer
oncology
drug development
devices
Flag link:
Bluebird taps Gritstone for oncology cell therapy targets
Bluebird taps Gritstone for oncology cell therapy targets
Fierce Biotech
Bluebird Bio
Gritstone Oncology
oncology
T-cell receptors
drug development
Flag link:
Novo Nordisk adds to diabetes pipeline with Evotec deal
Novo Nordisk adds to diabetes pipeline with Evotec deal
Fierce Biotech
Novo Nordisk
Evotec
drug development
small molecule drugs
obesity
diabetes
Flag link:
Artificial intelligence in drug discovery and diagnosis
Artificial intelligence in drug discovery and diagnosis
Pharmaforum
artificial intelligence
machine learning
diagnostics
drug development
Flag link:
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
RAPS.org
FDA
JNJ
Janssen
Lundbeck
Takeda
major depressive disorder
drug development
Flag link:
Pfizer Is Keeping Details of New 'Rescue Pen' Low Key, for Now
Pfizer Is Keeping Details of New 'Rescue Pen' Low Key, for Now
Medical Devices and Diagnostics Industry
Antares Pharma
Pfizer
QuickShot autoinjector
drug delivery
drug development
Flag link:
Discovery of unknown lung cell points to new target for cystic fibrosis medicines
Discovery of unknown lung cell points to new target for cystic fibrosis medicines
Stat
cystic fibrosis
drug discovery
drug development
Flag link:
Constrained peptides’ time to shine?
Constrained peptides’ time to shine?
Nature
drug development
clinical trials
R&D
contstrained peptides
Flag link:
Anima, Eli Lilly pen $1B-plus biobucks research pact
Anima, Eli Lilly pen $1B-plus biobucks research pact
Fierce Biotech
Eli Lilly
Anima
biotech
translation inhibitors
drug development
Flag link:
PureTech Receives Up To $36 Million from Roche to Develop Oral Delivery of Antisense Oligonucleotides
PureTech Receives Up To $36 Million from Roche to Develop Oral Delivery of Antisense Oligonucleotides
CP Wire
PureTech
Roche
drug development
antisense
Flag link:
Verge Genomics Scores $32 Million for AI-Driven Drug Discovery
Verge Genomics Scores $32 Million for AI-Driven Drug Discovery
CP Wire
Verge Genomics
drug development
artificial intelligence
Flag link:
Are We on the Cusp of a Big Alzheimer's Disease Breakthrough?
Are We on the Cusp of a Big Alzheimer's Disease Breakthrough?
Motley Fool
Alzheimer's disease
clinical trials
Biogen
drug development
BAN2401
Flag link:

Pages